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Abstract
In this study, using an immunoprecipitation coupled with mass spectrometry approach, we have identified the E3 ubiquitin ligase Trim21 as an
interacting partner of IFI35 and Nmi. We found that this interaction leads to K63-linked ubiquitination on K22 residue of Nmi, but not IFI35. Using domain deletion analysis, we found that the interaction is mediated via the coiled-coil domain of Nmi and the carboxyl-terminal SPRY domain of Trim21. Furthermore, we show that depletion of Trim21 leads to significantly reduced interaction of Nmi with IFI35, which results in the
abrogation of the negative regulatory function of the Nmi-IFI35 complex on innate antiviral signaling. Thus, Trim21 appears to be a critical regulator of the functions of the Nmi-IFI35 complex. Overall, the results presented here uncover a new mechanism of regulation of the Nmi-IFI35
complex by Trim21, which may have implications for various autoimmune diseases associated uncontrolled antiviral signaling.
Keywords: Trim21, IFI35, Nmi, ISG, Innate antiviral signaling, Ubiquitination

Introduction

IFI35 is known to interact with the cellular protein, N-myc and
STAT interacting protein (Nmi), another interferon-inducible protein (Zhou et al., 2000). Nmi was recently shown to negatively
regulate virus-induced type-I IFN production by promoting K48linked ubiquitination and proteasome-mediated degradation of
IRF-7 (Wang et al., 2013). Although IFI35 and Nmi have been
shown to be part of a high molecular mass complex (Chen et al.,
2000), possibly comprising of other cellular proteins, it appears
that they regulate the antiviral pathways by acting on different targets. Since, IFI35 and Nmi do not have any classical E3 ligase domains, it is possible that they recruit one or more E3 ubiquitin ligases to the complex to mediate their negative regulatory function
on the innate antiviral pathways.
Among the various immune regulatory mechanisms, ubiquitination is one of the major forms of post-translational modifications that can positively or negatively regulate the innate immune
response (Maelfait and Beyaert, 2012). The tripartite motif (Trim)
proteins are a family of highly conserved E3 ubiquitin ligases,
which conjugate ubiquitin on target proteins and have been shown
to be important regulators of antiviral signaling (Versteeg et al.,
2014). Trim proteins are defined by the presence of a conserved
N-terminal RBCC motif whereas the C-terminus is variable. The
RBCC motif contains the RING domain which is involved in catalyzing ubiquitin conjugation, the B-box domain which may aid
in E2 ubiquitin ligase binding and stabilization, and the coiledcoil domain which is required for homo and hetero-dimerization

The cellular innate immune response is an evolutionarily conserved
mechanism to fight infections caused by invading pathogens. This
response involves the activation of membrane bound Toll-like receptors (TLRs) or cytoplasmic sensors (RIG-I, MDA5 and STING)
of foreign macromolecules including RNA and DNA. This leads to
activation of a range of transcription factors such as IRF-3, IRF5, IRF-7 and NF-kB, which can then induce a vast array of antiviral genes [interferon (IFN) stimulated genes or ISGs] or cytokines via stimulation of IFN synthesis (Egli et al., 2014; Randall
& Goodbourn, 2008).
The innate immune pathways need to be tightly regulated by the
host cells in order to prevent excessive IFN production that would
otherwise be detrimental to the host. Some autoimmune diseases
such as systemic lupus erythematosus (SLE) and rheumatoid arthritis are associated with unregulated innate immune response resulting from excessive production of type-I IFNs (James, 2014).
Interestingly, some ISGs have been shown to function as negative
regulators of the innate immune response by targeting various components of the signaling pathway (Richards and Macdonald, 2011).
We recently reported that the ISG, interferon inducible protein 35
(IFI35), functions as a negative regulator of RJG-I signaling pathway by targeting RJG-I for proteasomal degradation (Das et al.,
2014), although the host protein that ubiquitinates RIG-I in this
IFI35-mediated negative regulatory pathway remains unidentified.
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(Freemont, 2000). In the recent years, functional roles of various
Trim proteins have been elucidated. One subset of Trim proteins
that include Trim5, Trim14, Trim15, and Trim44 has been shown
to positively regulate the antiviral response by ubiquitinating multiple targets in the pathway (Ottosson et al., 2006; Reymond et
al., 2001; Uchil et al., 2013; Yang et al., 2013). On the other hand,
Trim21, Trim27, Trim30 and Trim38 were recently shown to function as negative regulators of the antiviral response by mediating
proteasomal degradation of various signaling factors (Higgs et al.,
2008; Shi et al., 2008; Zhao et al. 2012; Zurek et al. 2012). Interestingly, some Trims like Trim21 are functionally flexible and can
regulate the innate immune pathway in a positive or negative manner. Trim21 was first identified as an intracellular antibody receptor that can strongly bind to the Fc regions of antibodies found in
complex with neutralized virus particles (Vaysburd et al., 2013).
Later, Trim21 was shown to activate the NF-κB, AP-1 and IRF-3/7
mediated antiviral pathways by conjugating K63-linked ubiquitin
chains whereas Trim21 was also recently found to down-regulate
the DNA sensor DDX41 by 1<48- linked ubiquitination and subsequent proteasomal degradation (Zhang et al., 2013). Physiologically, Trim21 has been found to be an autoantigen in autoimmune
diseases like rheumatoid arthritis, SLE and Sjogren’s syndrome.
Importantly, presence of antibodies against Trim21 are diagnostic markers of these diseases and their progression (James, 2014).
In our studies to understand further the role of IFI35 in regulating innate antiviral signaling, we have identified Trim21 as an inter-
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acting partner of IFI35 using an immunoprecipitation coupled with
mass spectrometry approach. We show that Trim21 interacts with
IFI35 as well as its partner protein, Nmi, but found that Trim21
conjugates K63-linked polyubiquitin chains exclusively on Nmi.
We demonstrate that Trim21 mediated K63-linked ubiquitination
of Nmi is required to form stable Nmi-IFI35 complex and also to
promote the negative regulatory function of this complex on the
innate antiviral response. Our results establish the role of Trim21
as a negative regulator of innate antiviral response by modulating
the K63-linked ubiquitination of Nmi and its interaction with IFI35.
Results
Trim21 is an interacting partner of IFI35 and Nmi
To identify cellular factors that may regulate IFI35 function and
thereby may promote the IFI35-mediated inhibition of the IFN response, we expressed 3xFlag-tagged IFI35 (3xFlag-IFI35) in 293T
cells and performed immunoprecipitation (IP) using an anti-Flag
antibody. The immunoprecipitates were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), silver-stained and
the unique protein bands identified in the immunoprecipitates were
subjected to liquid chromatography-mass spectrometry (LC-MS)
analysis. From this analysis, we identified Trim21, which was present only in the immunoprecipitates of cells expressing the 3xFlagIFI35 but not in cells transfected with the empty vector (Figure

Figure 1. Trim21 interacts with IFI35 and Nmi. (A) HEK 293T cells were transfected with 5 μg of 3xFlag-EV and 3xFlag-IFI35 plasmids. At 24 h post transfection (hpt), cell lysates were subjected to immunoprecipitation with anti-Flag monoclonal antibody (Mab), separated on 10% SDS-PAGE and silver stained. Molecular mass markers (in kDa) are shown in lane M. The bands containing Trim21 and 3xFlag-IFI35, as identified by LC-MS analysis. are indicated with arrows.
(B) HEK 293T cell lysates were subjected to immunoprecipitation with anti-IFI35 antibody and immunoblotting with anti-Trim21 antibody. (C) HEK 293T cell
lysates were subjected to immunoprecipitation with anti-Nmi antibody and immunoblotting with anti-Trim21 antibody. (D) THP-1 cell lysates were subjected to
immunoprecipitation with anti-IFI35 antibody and immunoblotting with anti-Trim21 antibody. (E) THP-1 cell lysates were subjected to immunoprecipitation with
anti-Nmi antibody and immunoblotting with anti-Trim21 antibody. Expression of the endogenous proteins in the whole cell lysates (WCLs) were analyzed by immunoblotting with the indicated antibodies. Approximate positions of the molecular weight markers (in kDa) are shown on the right side of the blots.
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1A). To confirm further the interaction between Trim21 and IFI35,
we performed co-immunoprecipitation of the endogenous proteins
in 293T (non-immune) and THP-l (immune) cells and found that
the two proteins interact with each other in both cell types (Figure 1B and D). We considered the possibility that this interaction
may be mediated through other factors, as IFI35 is known to exist in high molecular mass complexes with the interferon-inducible N-Myc and STAT interactor (Nmi) (Chen et al., 2000; Zhou
et al., 2000). Thus, we examined if any interaction exists between
Trim21 and Nmi and found that the two proteins interact at the endogenous level in both the cell types (Figure 1C and E). Overall,
these results show that IFI35, Nmi, and Trim21 interact with each
other and may form the high molecular mass complexes described
previously for Nmi and IFI35.
Trim21 mediates K63-1inked ubiquitination of Nmi
Since Trim21 is a well characterized E3 ubiquitin ligase shown to
mediate auto-ubiquitination as well as ubiquitination of a variety
of substrates (Oke and Wahren-Herlenius, 2012) for their degradation or activation, we first examined if Trim21 interaction with
IFI35 and Nmi led to ubiquitination of these proteins. Interestingly, we observed significant ubiquitination of Nmi in cells overexpressing Trim21, but very low level of IFI35 ubiquitination was
found under similar conditions (Figure 2A). This suggests that although Trim21 interacts with both Nmi and IFI35, it primarily targets Nmi for ubiquitination. Since, Trim21 is known to mediate
both K63- and K48-linked ubiquitination of substrates (McEwan
et al., 2013; Zhang et al., 2013), we examined the type of ubiqui-
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tin linkage on Nmi by over-expressing HA-tagged ubiquitin mutants (K48 only and K63 only) along with Trim21. Results show
that Trim21 expression led to significant K63-linked ubiquitination but not K48-linked ubiquitination of Nmi (Figure 2B). Furthermore, treatment of cells with the proteasomal inhibitor MG132
led to detection of minimal levels of K48-linked ubiquitination of
Nmi (Figure 2B), suggesting that Nmi primarily undergoes K63linked ubiquitination in the presence of Trim21. Since K63-linked
ubiquitination typically results in activation of target proteins (Davis & Gack, 2015), our data suggests that Nmi may be activated
through this modification.
Trim21 belongs to the Trim family of proteins, many of which
contain the tripartite motifs at their N-terminal RBCC domains
(Ottosson et al., 2006; Reymond et al., 2001) that include a RING
finger encoding E3 ubiquitin ligase (Freemont, 2000), a B-box
and a coiled-coil domain mediating oligomerization. To demonstrate that the ubiquitination of Nmi was mediated specifically by
Trim21 activity, we generated a catalytically inactive Trim21 mutant (Trim21 ΔRING) and found that this mutant failed to ubiquitinate Nmi (Figure 2C). Collectively, these data indicate that Trim21
mediates K63-linked ubiquitination of Nmi, which in turn may promote Nmi activation or its interaction with partner protein, IFI35.
Trim21 interacts with the coiled-coil domain of Nmi via its SPRY
domain
To map the domains involved in the interaction between Trim21
and Nmi, we generated a series of deletion mutants of Trim21 and
Nmi based on characterized functional domains of these proteins.
Figure 2. Trim21 mediates K63-linked ubiquitination of Nmi.
(A) HEK 293T cells were transfected with
1 μg each of 3xFlag-Nmi or 3xFlag-IFI35
along with 0.5 μg each of Trim21-3xMyc
and HA-Ub. At 24 hpt, cell lysates were
subjected to immunoprecipitation with
anti-Flag polyclonal antibody. Ubiquitination of Nmi and IFI35 were detected using
anti-HA Mab. Expression of proteins from
transfected plasmids were analyzed in the
WCLs using the indicated antibodies.
(B) Cells were transfected with 1 μg of
3xFlag-Nmi along with 0.5 μg each of
Trim21-3xMyc, HA-Ub-K63, or HA-UbK48 plasmids. At 24 hpt, cells were treated
with 10 μM MG132 or equivalent amount
of vehicle (DMSO) for 12 h and cell lysates were subjected to immunoprecipitation with anti-Flag polyclonal antibody.
Ubiquitination of Nmi was detected using
anti-HA Mab. Expression of proteins from
transfected plasmids were analyzed in the
MG132 treated and untreated WCLs using
the indicated antibodies.
(C) Cells were transfected with 1 μg of
3xFlag-Nmi along with 0.5 μg each of HATrim21 or HA-Trim21 ΔRING plasmids.
At 24 hpt, cell lysates were subjected to
immunoprecipitation with anti-Flag polyclonal antibody. Ubiquitination of Nmi was
detected using anti-Ub antibody. Expression of proteins from transfected plasmids
were analyzed in the WCLs using the indicated antibodies. Approximate positions of
the molecular weight markers (in kDa) are
shown on the right side of the blots.
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Nmi contains a coiled-coil (CC) domain at its amino-terminus and
two N-myc interacting domains (NID1 and NID2) toward the carboxyl-terminus (Zhang et al., 2007b). These domains were individually deleted from the full-length Nmi as shown in Figure 3A. Using co-IP assays, we found that deletion of the CC region of Nmi
abrogated its interaction with Trim21, whereas NID1 and NID2 domain deletion mutants could still interact with Trim21 (Figure 3B).
This suggests that the CC domain of Nmi is essential for interaction
with Trim21. Similarly, to identify the region(s) of Trim21 that interacts with Nmi, we deleted either the N-terminal RING (catalytic)
domain, the central B-Box, the coiled-coil (CC) domain, the PRY
and SPRY domains individually or together (Figure 3C). Examination of interaction of these deletion mutants with Nmi showed
that Trim21 lost interaction with Nmi only when SPRY domain
was deleted (Figure 3D). Overall, these data suggest that Trim21
requires its SPRY domain to interact with the CC region of Nmi.
Trim21 ubiquitinates Nmi predominantly on lysine 22 residue
To identify the lysine residue(s) that are the targets of Trim21 mediated ubiquitination, we analyzed the Nmi amino acid sequence
using an ubiquitination site prediction tool (http://www.ubpred.
org). We found eight lysine (K) residues (at amino acid positions 5,
13, 22, 27, 56, 61, 176, and 183) of high and medium confidence,
which could be potentially used for conjugation of ubiquitin chains.
To identify the K residue(s) targeted by Trim21 for ubiquitination, we initially constructed four double K mutants of Nmi (K5R/
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K13R, K22R/K27R, K56R/K61R, and K176R/K183R) by mutating the K residues into arginines (R). Since, we have previously
shown (Figure 2B) that Trim21 mediates K63-linked ubiquitination of Nmi, we tested these mutant Nmi constructs for their ability to be ubiquitinated by Trim21 via K63-linked ubiquitin chains.
Our results show that mutation of both the K22 and K27 residues
led to significantly reduced ubiquitination of Nmi (Figure 4A).
All the other double lysine mutants including the K176R/K183R
mutant (in which the mutations are located outside of the CC domain), showed similar level of ubiquitination as the wild type (wt)
protein. These data indicate that one or both of the K residues at
positions 22 and 27 are required for Trim21 mediated ubiquitination of Nmi. To determine if one or both of these K residues are
used for K63-linked ubiquitination, we generated single K22R and
K27R mutants of Nmi and in a similar ubiquitination assay found
that K22R mutant lost the ability to be ubiquitinated by Trim21,
while the K27R mutant was ubiquitinated to similar extent as the
wt protein (Figure 4B). Collectively, these data suggest that the
K22 of Nmi serves as the major acceptor site of K63-linked ubiquitination mediated by Trim21.
Trim21 is required for Nmi-IFI35 interaction
Previous reports have suggested that Nmi and IFI35 form steady
state high molecular mass complexes, wherein Nmi prevents the
proteasomal degradation of IFI35 (Chen et al., 2000). The identity of other cellular components, if any, in these high molecular
Figure 3. Trim21 interacts with the
coiled-coil domain of Nmi via its SPRY
domain.
(A) Schematic of the construction of
domain deletion mutants of Nmi. F,
Flag tag. Approximate amino acid positions of the domains are shown at
the top. Various domains are boxed
and discontinuous lines represent deletion of those regions.
(B) The indicated domain deletion mutants of Nmi along with HA-Trim21
were transfected into HEK 293T
cells. At 24 hpt, cell lysates were
subjected to immunoprecipitation
using anti-HA Mab. Interacting proteins were identified by immunoblotting with anti-Flag Mab. Expression
of proteins from transfected plasmids
were analyzed in the WCLs using the
indicated antibodies.
(C) Domain organization and deletion
mutants of Trim21. H, HA tag. Approximate amino acid positions of the
domains are shown at the top. Various domains are boxed and discontinuous lines represent deletion of those
regions.
(D) The indicated domain deletion mutants of Trim21 along with 3xFlagNmi were transfected into HEK 293T
cells. At 24 hpt, cell lysates were subjected to immunoprecipitation using
anti-Flag Mab. Interacting proteins
were identified by immunoblotting
with anti-HA Mab. Expression of proteins from transfected plasmids were
analyzed in the WCLs using the indicated antibodies. Approximate positions of the molecular weight markers (in kDa) are shown on the right
side of the blots.
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mass complexes, is not known at this time; however, our findings
that Trim21 interacts with both IFI35 and Nmi suggest that this E3
ubiquitin ligase maybe a part of this complex. Since, we have demonstrated that Trim21 ubiquitinates Nmi via K63-linkage, which in
turn may activate Nmi function, we wondered if Trim21 also facilitates the interaction of Nmi and IFI35. To this end, we depleted the
endogenous Trim21 using siRNAs and performed co-IP assays to
determine if IFI35 and Nmi could still interact. Our results show
that depletion of Trim21 led to significantly reduced interaction of
Nmi with IFI35 (Figure SA). Likewise, when we performed immunoprecipitation with IFI35 antibody and immunoblotting with
Nmi antibody, we detected significantly reduced level of Nmi being immunoprecipitated in cells depleted of Trim21 58).
The above results were further strengthened with studies,
wherein we transfected the siRNA-mediated Trim21-depleted cells
with wt or a siRNA resistant mutant Trim21 (Trim21-siR) and examined the interaction of Nmi and IFI35. Indeed, the interaction
of Nmi and IFI35 was restored in Trim21-depleted cells expressing the Trim21-siR but not in the cells expressing wt Trim21 (Figure 5C), since, the exogenously and endogenously expressed wt
Trim21 was depleted by the siRNA. Overall, these data suggest that
Trim21 is required to facilitate the interaction of Nmi and IFI35
and likely plays a critical role in regulating the function(s) of the
Nmi-IFI35 complex.
Trim21 regulates Nmi-mediated inhibition of the innate antiviral response
In a previous study, it was reported that Nmi promotes K48-linked
ubiquitination and proteasome-mediated degradation of the transcription factor IRF-7, thereby inhibiting the innate antiviral signaling (Wang et al., 2013). Since, we found that Trim21 mediates
K63-linked ubiquitination of Nmi, we asked if this modification in
Nmi has any functional role in negative regulation of the antiviral
response. To this end, we examined the levels of IFN-β (IFNB1)
mRNA in 293T cells overexpressing the wt or the various K mutants (K22R, K27R, and K22R/K27R) of Nmi. Our results showed
that upon Sendai virus (SeV) infection to induce IFN synthesis,
levels of IFN-β mRNA was about 4-fold lower in Nmi overexpressing cells compared to the control cells (empty vector trans-

387

fected) not expressing Nmi (Figure 6A), indicating that Nmi overexpression suppresses IFN-β production. This is consistent with
the previously described inhibitory role of Nmi on IFN production
(Wang et al., 2013). Interestingly, the K22R mutant was unable to
suppress IFN-β mRNA induction, whereas the K27R mutant suppressed IFN-β mRNA induction to levels similar to that observed
with wt Nmi. The K22R/K27R double mutant moderately suppressed IFN-β mRNA levels (Figure 6A). To examine if the establishment of an antiviral state (IFN-β production) was similarly affected in the cells expressing the wt and various mutant Nmi, we
performed a VSV-IFN bioassay by examining the growth of GFPtagged vesicular stomatitis virus (VSV-GFP) in 293T cells pretreated with supernatants from the experiment described in Figure
6A. We found that VSV-GFP grew to higher titers in cells treated
with supernatants from cells expressing wt or K27R mutant Nmi
(9.7 × 105 pfu/ml and 8.7 × 105 pfu/ml, respectively) compared to
that in cells treated with supernatants from empty vector transfected
cells (1.5 × 105 pfu/ml). However, VSV-GFP growth was inhibited
to similar extent in cells treated with supernatants from cells expressing K22R (4 × 105 pfu/ml) or K22R/K27R mutants (3.3 × 105
pfu/ml) (Figure 6B). Together, these data suggest that K63-linked
ubiquitination of Nmi at K22 but not K27, is important for its negative regulatory function on IFN production.
To confirm these findings further, we used specific siRNAs to deplete endogenous Trim21 in cells overexpressing Nmi and then quantified the IFN-β mRNA expression. In comparison to control siRNA
(NT) transfected cells, SeV infection of Trim21 siRNA transfected
cells led to significant induction of IFN-β mRNA in the presence of
Nmi overexpression (Figure 6C). Importantly, overexpression of a
Trim21 siRNA resistant plasmid in cells treated with Trim21 siRNA
could restore the Nmi-mediated suppression of IFN-β mRNA expression (Figure 6C). The antiviral state of these cells was examined in a
similar VSV-IFN bioassay as described for Figure 6B. We observed
that depletion of Trim21 in Nmi overexpressing cells led to reduced
virus replication (2.4 × 105 pfu/ml) compared to control cells not depleted of Trim21 (8.7 × 105 pfu/ ml). The suppression of virus replication was rescued in cells overexpressing the siRNA-resistant form
of Trim21 (6.3 × 105 pfu/ ml) (Figure 6D). Taken together, these results suggest that Trim21 regulates Nmi-mediated inhibition of antiviral response by K63-linked ubiquitination of Nmi.
Figure 4. Trim21 ubiquitinates Nmi on lysine 22 residue.
(A) HEK 293T cells were transfected with
1 μg each of a panel of double lysine
mutants of Nmi (Flag-tagged) along
with 0.5 μg each of Trim21-3xMyc and
HA-Ub-K63 plasmids. At 24 hpt, the
cell lysates were subjected to immunoprecipitation using anti-Flag Mab. K63linked ubiquitination of Nmi was detected using anti-HA Mab. Expression
of the proteins from transfected plasmids were analyzed in the WCLs using
the indicated antibodies.
(B) Similar experiment was performed as
described in panel A, except the single
lysine mutants of Nmi were used. Approximate positions of the molecular
weight markers (in kDa) are shown on
the right side of the blots.
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Discussion
This study advances our current understanding of an immune regulatory complex that includes the interferon stimulated genes Nmi,
IFI35, and Trim21. Here, we have identified the E3 ubiquitin ligase, Trim21, as an interacting partner of IFI35 through an immunoprecipitation coupled with mass spectrometry screen. Interestingly, we found that Trim21 also interacts with Nmi, which is
a known binding partner of IFI35. Both Nmi and IFI35 together
have been shown to form a 200–300 kDa high molecular mass
complex (Chen et al., 2000; Zhou et al., 2000). Various studies
have identified several interacting partners of IFI35 and Nmi that
maybe a part of the complex. Previous studies have shown B-ATF
(member of AP-1 family of transcription factors) and CKIP-1 as
interacting partners of IFI35 and Nmi and that these interactions
were demonstrated to regulate antiviral gene transcription and cytokine response (Wang et al., 1996; Zhang et al., 2007b). Our recent work revealed an interaction between the cytoplasmic RNA
sensor RIG-I and IFI35 and showed that this interaction resulted
in down-regulation of RIG-I signaling due to K48-linked ubiquitination and degradation through the proteasome machinery (Das
et al., 2014). Here, we have shown that the interaction of Trim21
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with Nmi and IFI35 occurs in nonimmune (HEK 293T) as well as
immune (THP-1) cells, indicating that the mechanism of Trim21mediated regulation of Nmi-IFI35 complex may be relevant in
both cell types.
In this work, we have uncovered a previously undescribed role
of Trim21 in regulating the formation of Nmi-IFI35 complex by
mediating K63-linked ubiquitination of Nmi. Based on our recent
findings (Das et al., 2014), we initially hypothesized that Trim21
might be down-regulating RIG-I activation through K48-linked
ubiquitination, although our studies did not reveal ubiquitination
of RIG-I by Trim21 (data not shown). This is consistent with a report showing no change in RIG-I levels in cells overexpressing
Trim21 (Zhang et al., 2013). Our previous observation that overexpression of IFI35 led to K48-linked ubiquitination and degradation of RIG-I suggests that yet another unidentified E3 ubiquitin ligase in association with IFI35 might be responsible for K48-linked
ubiquitination of the RIG-I. Interestingly, here we found that although Trim21 interacts with both Nmi and IFI35, it primarily
ubiquitinates Nmi. Furthermore, Trim21 may act as an intermediary molecule that facilitates the interaction of Nmi and IFI35,
since depletion of Trim21 abrogates their interaction. The interaction of Trim21 and Nmi leads to conjugation of K63-linked ubiquiFigure 5. Trim21 is required for Nmi-IFI35
interaction.
(A) HEK 293T cells were transfected with 10
nM of control (NT) or Trim21 siRNA for 72
h. Cell lysates were subjected to immunoprecipitation with isotypic IgG control antibody
or anti-Nmi antibody. Presence of endogenous IFI35 in the immunoprecipitates was
detected by anti-IFI35 antibody. Endogenous
expression of proteins in the WCLs was analyzed by using the indicated antibodies.
(B) Similar experiment was performed as in
panel A, except the cell lysates were subjected to immunoprecipitation with isotypic
IgG control antibody or anti-IFI35 antibody.
Presence of endogenous Nmi in the immunoprecipitates was detected by anti-Nmi
antibody.
(C) Cells were transfected with 10 nM of control (NT) or Trim21 siRNA (siTrim21) for
48 h. Subsequently. cells were re-transfected with 2 μg each of Myc-tagged wildtype Trim21 (Trim21-wt) or siRNA resistant
mutant (Trim21-siR) plasmids for another 24
h. Finally, the cell lysates were subjected to
immunoprecipitation with anti-Nmi antibody.
Presence of endogenous IFI35 in the immunoprecipitates was detected by anti-IFI35 antibody. Expression of endogenous and exogenously expressed proteins in the WCLs was
analyzed by using the indicated antibodies.
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tin chains on Nmi, which further facilitates the formation of NmiIFI35 complex.
The stability of Nmi appears to play important roles in cellular
functions. It was previously reported that Tip60 (a histone acetyltransferase) enhances the stability of Nmi by preventing its proteasomal degradation, although the detailed mechanism remains
unclear (Zhang et al., 2007a). Nmi has also been shown to confer
stability of cellular proteins, for instance the association of Nmi
with IFI35 in the high molecular mass complex is required to prevent proteasomal degradation of IFI35 (Chen et al., 2000). It is not
clear what signals are necessary for degradation of IFI35; however, our results indicate a requirement for Trim21-mediated K63linked ubiquitination of Nmi to facilitate interaction with IFI35
and possibly with other proteins in the complex. We did not observe any change in overall protein levels of Nmi or IFI35 when
Trim21 was depleted (Figure 5A and B), although the interaction of
Nmi and IFI35 was significantly reduced. This suggests that K63linked ubiquitination of Nmi is required to facilitate the interaction but does not affect stability of these proteins. Thus, our study
highlights an important role of Trim21 in modulating the function
of Nmi-IFI35 complex.
Trim21 is known to regulate function of various antiviral signaling proteins. A previous study demonstrated that Trim21 activates various components of IFN signaling pathway by conjugating
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Figure 7. Proposed model depicting the role of Trim21 in regulation of Nmimediated negative regulation of the innate antiviral response. Infection with
RNA viruses like VSV or SeV leads to activation of the innate antiviral pathways, resulting in production of IFN-α/β, which in turn leads to induction of
many ISGs including Trim21, Nmi, and IFI35 as shown here. Trim21 interacts
with both Nmi and IFI35 but primarily ubiquitinates Nmi on K22 residue via
K63-linked ubiquitination. This facilitates interaction between Nmi with IFI35,
which then in a negative feedback manner leads to inhibition of IFN-β production, resulting in an overall downregulation of the innate antiviral signaling.

K63-linked ubiquitin chains (McEwan et al., 2013). A recent study
also found Trim21 as a negative regulator of DNA sensing pathway by mediating K48-linked ubiquitination and degradation of the

Figure 6. Trim21 regulates Nmi-mediated inhibition of the innate antiviral response. (A) HEK 293T cells were transfected with an empty vector (EV) control or
the indicated Nmi lysine mutants. At 24 hpt, these cells were infected with 80 HA units/ml of SeV for another 16 h. Finally, total RNA was extracted from these
cells for qRT-PCR assay. IFNB1 and GAPDH mRNA levels were determined using specific Taqman primer and probes. Values were normalized to the internal control GAPDH and expressed as relative fold changes compared to mock-infected cells transfected with the EV. Expression of the Nmi lysine mutants (Nmi K mut)
are shown in the immunoblots. Actin served as the loading control. (B) VSV-IFN bioassay. Supernatants from the experiment described in panel A, were UV-inactivated and added to fresh HEK 293Tcells and incubated for 12 h. Then, cells were infected with 0.1 MOI VSV-GFP for another 16 h. Finally, the supernatants
were used to determine VSV titers (pfu/ml) by plaque assay on BHK-21 cells. (C) Cells were transfected with 10 nM of NT or siTrim21 for 48 h. Subsequently,
NT-transfected cells were re-transfected with an EV or Nmi encoding plasmids, whereas siTrim21-transfected cells were re-transfected with Nmi alone or in combination with Trim21-siR plasmids for another 24 h. Finally, IFNB1 mRNA was quantitated as described in panel A. Expression of Nmi and Trim21 are shown in
the immunoblots. Actin served as the loading control. (D) Supernatants from the experiment described in panel C, were UV-inactivated, added to fresh HEK 293T
cells and VSV-IFN bioassay was performed as described in panel B. Data presented in the panels are from three independent experiments and the values represent
mean and SD for duplicate samples. * P < 0.05, ** P < 0.01.
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DNA sensor DDX41 (Zhang et al., 2013). Our data suggests that
Trim21 functions as a negative regulator of antiviral signaling by
modulating the activity of the Nmi-IFI35 complex (Figure 7). We
show that K63-linked ubiquitination of Nmi on the lysine 22 residue is required to maintain the negative regulatory function as mutation of the lysine to arginine leads to significantly higher antiviral response. Since, we measured the IFN-β mRNA levels as the
readout for antiviral response, we cannot discern if Trim21 mediated K63-linked ubiquitination of Nmi negatively regulates only
RIG-I/IRF-7 axis of signaling or other antiviral pathways as well.
Thus, further work involving global pathway analysis using highthroughput platforms such as RNA-seq, may shed light on whether
Trim21-mediated regulation of Nmi-IFI35 complex is a stand-alone
mechanism or part of a larger regulatory network to control excessive IFN production.
Materials and methods
Cells, viruses and reagents
Human embryonic kidney HEK 293T cells were obtained from
ATCC (Manassas, VA) and maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and the antibiotics (PKS): penicillin (100 units/ml), kanamycin (20 units/ml) and streptomycin (20 units/ml). Baby hamster kidney (BHK-21) cells were maintained in modified Eagle’s medium
(MEM) supplemented with 5% FBS and lX PKS. THP-l cells (gift
from Dr. Tom Petro, University of Nebraska Medical Center) were
maintained in Roswell Park Memorial Institute Medium (RPMI)
supplemented with 10% FBS, lX PKS and 1 mM sodium pyruvate.
MG132 was purchased from Cayman Chemicals (Ann Arbor, MI).

Sendai virus (SeV) Cantell strain was purchased from Charles
River laboratories. SeV infections were performed at 80 haemagglutinin units per ml (HA units/ml) for 16 hours (h). Stocks of VSV-GFP
were prepared in the lab as described previously (Dinh et al., 2011).
For the VSV-IFN bioassay, HEK 293T cells were infected with VSVGFP at an MOI of 0.1 plaque forming unit (PFU) per cell for 14 h.
Virus titers were determined by plaque assays on BHK-21 cells.
Antibodies
Anti-Flag mouse monoclonal antibody (Mab; clone M2), anti-Flag
and anti-HA rabbit polyclonal antibodies were purchased from
Sigma Aldrich Inc. Anti-HA (mouse Mab; clone HA.11) was purchased from Covance Inc. Anti-c-Myc (clone 9E1; sc-40), anti-Actin (sc-47778), anti-IFI35 (sc-100769), anti-Nmi (sc-101100), antiUb (sc-8017) and anti-Trim21 (sc-25351) Mabs were purchased
from Santa Cruz Biotechnology Inc. HRPO-conjugated goat antimouse (A4416) and goat anti-rabbit (A6154) antibodies were purchased from Sigma Aldrich Inc. For immunofluorescent staining,
Alexa Fluor 488-conjugated donkey anti-mouse IgG (A21202), Alexa Fluor 647-conjugated donkey anti-rabbit IgG (A-31573) were
purchased from Life Technologies Inc.
Plasmid constructs
3xFlag-IFI35 construct has been described previously (Das et
al., 2014). 3xFlag-Nmi was constructed in a similar manner by
cloning PCR amplified Nmi cDNA from 293T cells into a modified pcDNA-3xFlag vector at the KpnI and NotI sites. The Nmi
domain deletion mutants namely ΔCC (Δ1-92), ΔNIDl (Δ103192) and ΔNID2 (Δ201-292) were constructed on the 3xFlag-

Table1. Primers used in this study.
Primer name

Sequence (5ʹ to 3ʹ)

Purpose

ΔCC-R
ΔCC-F
ΔNID1-R
ΔNID1-F
ΔNID2-R
ΔNID2-F
Nmi KpnI-F
Nmi NotI-R
ΔRING-R
ΔRING-F
ΔBBOX-R
ΔBBOX-F
ΔSPRY-R
ΔSPRY-F
Trim21sires-F
Trim21sires-R
K5RK13R-F
K5RK13R-R
K22RK27R-F
K22RK27R-R
K56RK61R-F
K56RK61R-R
K176RK183R-F
K176RK183R-R
K22R-F
K22RK27R-R
K27R-F
K22RK27R-R
Trim21 KpnI-F
Trim21 NotI-R
Trim21 KpnI-F
Trim21NS NotI-R

GGTACCAAGCTTGTCATCG
AGCTCGAAAGTTCCTTATGAG
TTTTTGTATCTCATAAGGAACTTTCG
CGCGTGGACTATGACAGAC
GGACTGTCTGTCATAGTCC
GTCAAGTGTTCTCTAGGTCAAC
ATATATGGTACCATGGAAGCTGATAAAGATGAC
ATATATGCGGCCGCCTATTCTTCAAAGTATGCTATG
GACCTCCTCCCACATCATTG
CTGCTCAAGAATCTCCGGC
TTCCCCCTGTGTGCCCTC
GAGGAGGCTGCACAGGAG
ACATGTCCTCAGCATCTTCTTC
CCACTGAATATTGGATCACAAGG
GTCCTGTGTGTCGACAACGTTTCCTACTTAAGAATCTCCG
AGACGCTGCCCCCACCTTTCCCAACC
CTGATAGAGATGACACACAACAAATTCTTAGGGAGC
CTTCCATGGTACCAAGCTTGTCATCGTC
GAATTTATAAGAGATGAACAAAATAGGGGAC
ATCTGGCGAATGCTCCTTAAGAATTTG
CTACCAGAGAATTCCAGATTAGAGAGG
CCTCTTGTAACTCCGTTTCAAGC
GAGACAGACTAGAGCTGAGCTTTTCAAGGTCCCG
TCATTTGATCTTCACGCAATGTGTCAGG
GAATTTATAAGAGATGAACAAAATAAGGGAC
ATCTGGCGAATGCTCCTTAAGAATTTG
GAATTTATAAAAGATGAACAAAATAGGGGAC
ATCTGGCGAATGCTCCTTAAGAATTTG
ATATGGTACCATGGCTTCAGCAGCACGCTTG
ATATGCGGCCGCTCAATAGTCAGTGGATCCTTGTG
ATATGGTACCATGGCTTCAGCAGCACGCTTG
ATATGCGGCCGCATAGTCAGTGGATCCTTGTGATC

Construction of Nmi ΔCC mutant
Construction of Nmi ΔNID1 mutant
Construction of Nmi ΔNID2 mutant
Constructionof3xFlag-Nmi
Construction of Trim21 ΔRING mutant
Construction of Trim21 ΔBBOX mutant
Construction of Trim21 ΔSPRY-PRYmutant
Construction of Trim21siRNA resistant mutant
Construction of Nmi K5/K13 double mutant
Construction of Nmi K22/K27 double mutant
Construction of Nmi K56/K61 double mutant
Construction of Nmi K176/K183 double mutant
Construction of Nmi K2 2mutant
Construction of Nmi K27 mutant
Construction of HA-Trim21
Construction of Trim21-3xmyc

T r i m 2 1 r e g u l at e s N m i - I F I 3 5 c o m p l e x a n t i v i r a l r e s p o n s e

Nmi background using the Phusion site-directed mutagenesis approach (Thermo Scientific). A panel of double lysine (K) mutants
of 3xFlag-Nmi namely K5R/K13R, K22R/K27R, K56R/K61R,
K176R/K183R and single K mutants namely K22R and K27R were
generated using the Phusion site-directed mutagenesis approach.
The mutagenic primers used to mutate the K residues to R are listed
in Table 1. Trim21 tagged with HA at the N-terminus (HA-Trim21)
was constructed by cloning PCR amplified Trim21 cDNA from
293T cells into a modified pcDNA vector with HA-tag (pcDHA)
at the KpnI and NotI sites. HA-Trim21 was used as a template to
generate the domain deletion mutants, namely, ΔRING (Δ15-58),
ΔBBOX (Δ91-128), ΔCC (Δ130-255), ΔPRY (Δ286-334), ΔSPRY
(Δ335-463) and ΔSPRY-PRY (Δ286-463). A C-terminus 3xMyc
tagged Trim21 (Trim21-3xMyc) was also generated by cloning
PCR amplified Trim21 cDNA from 293T cells into pA3xmyc vector [gift from Dr. Charles Wood, University of Nebraska–Lincoln
(UNL)] at the KpnI and NotI sites. A Trim21 siRNA resistant plasmid (Trim21-3xMyc-siR) was constructed by mutating the siRNA
target region (nt positions 162–182 in the Trim21 ORF) using the
mutagenic primers (Table 1). N-terminus HA-tagged ubiquitin was
expressed from pMT123-HA-Ubiquitin plasmid which has been
described previously (Treier et al., 1994). pRK5-HA-Ubiquitin K48
(17605) and pRK5-HA-Ubiquitin K63 (17606) (Lim et al., 2005)
were purchased from Addgene.
siRNA-mediated silencing
To deplete the endogenous Trim21, we transfected Trim21 siRNA
duplex 2 from Qiagen (Qiagen # S100048251) at a concentration of
10 nM into 293T cells and incubated for 48–72 h. Similar concentration of non-targeting (NT) siRNA (Qiagen # 1027281) was used
as negative control. The depletion was confirmed by immunoblotting using antibody against endogenous Trim21 (sc-25351). For determination of IFN-β mRNA levels, quantitative Real Time PCR
(qRT-PCR) was performed. Total cellular RNA was extracted using Trizol (Invitrogen) according to manufacturer’s protocol. First
strand cDNA was synthesized with 2 μg of total RNA using MMLV reverse transcriptase (Invitrogen) according to manufacturer’s
protocol. The cDNA was diluted 2-fold and 100 ng of cDNA was
used for each qRT-PCR reaction. Taqman primers and probe mix
(20X) for IFNB1 or IFN-β (Hs01077958), GAPDH (Hs99999905)
and Taqman Gene expression master mix (2X) (Applied Biosystems) were added along with cDNA and water to a final volume of
20 μL per well. qRT-PCR reaction was carried out in MicroAmp
optical 96 well plates using the Step One Plus Real Time PCR
system (Applied Biosystems). The standard protocol for Taqman
based qRT-PCR provided by the manufacturer was used. Relative
fold changes in gene expression were automatically calculated by
the Step One Plus Real Time PCR system software (Applied Biosystems) following the ΔΔCT method.
Plasmid transfections and western blotting
Transfection of HEK 293T cells with plasmids was performed using Lipofectamine 2000 (Invitrogen) as per manufacturer’s instructions. Usually, 12 h after transfection, the cells were washed and
fresh growth media was added and incubated for 24–48 h. For
western blotting assays, dilutions of primary antibodies used were
as follows: anti-Flag MabM2 (1:4000), anti-HA Mab (1:4000),
anti-Myc Mab (1:2000), anti-Trim21 (1:1000), anti-Nmi (1:1000),
anti-IFI35 (1:1000), anti-Ub (1:2000) and anti-Actin (1:5000). The
corresponding HRPO conjugated secondary antibodies were used
at dilutions ranging from (1:2000 to 1:5000).
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Co-immunoprecipitation (Co-IP) assay
For interaction experiments, 6-well plates containing 70–80% confluent 293T cells were transfected with plasmids and incubated for
24 h. Following incubation, cells were lysed in radioimmunoprecipitation buffer without SDS (ROS lysis buffer), whose composition has been described earlier (Dinh et al., 2011). The lysates
were clarified by low speed centrifugation (15,000g) for 20 min
at 4 °C and incubated with the primary antibody overnight after
which 4 mg of protein A-Sepharose beads (GE Healthcare Bioscience AB) washed 3 times in the ROS lysis buffer was added to
each sample and incubated for 2–4 h. Beads with bound immune
complexes were thoroughly washed at least 3 times with the lysis buffer, 20-30 μl 2X SDS-polyacrylamide gel electrophoresis
(PAGE) sample preparation buffer was added, boiled for 5 min
and the proteins in the eluted samples were resolved in 10% SDSpolyacrylamide gel. Subsequently, the proteins were transferred
to polyvinylidene difluoride (PVDF) membrane and immunoblotting was carried out using antibodies as described in the western blotting section.
Silver staining and mass spectrometric (MS) analysis of proteins
For MS analysis, the immunoprecipitated proteins were separated
by SDS-PAGE, the proteins were stained using the silver staining
method described previously (Dinh et al., 2011), and the selected
bands were excised from the stained gel for liquid chromatography-mass spectrometry (LC–MS) analysis. Briefly, individual gel
pieces containing the protein(s) were digested by trypsin and the
digested peptides were extracted in 5% formic acid–50% acetonitrile and separated using a C18 reversed-phase LC column (75
μm by 15 cm; BEH 130, 1.7 μm, Waters, Milford, MA). A quantitative time of flight (Q-TOF) Ultima tandem mass spectrometer
with electrospray ionization (Waters) was used to analyze the eluting peptides. The peak lists of MS/MS data were generated using
Distiller (Matrix Science, London, United Kingdom) with charge
state recognition and deisotoping with the other default parameters
for Q-TOF data. Database searches of the acquired MS/MS spectra were performed using Mascot (Matrix Science, v2.2.0, London, United Kingdom).
Statistical analysis
Graphs were generated and statistical analyses were performed using Graph Pad Prism software (Graph Pad software Inc.). Statistical
significance between groups was determined by two-tailed paired
Student’s t test. P < 0.05 was considered statistically significant.
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